ALIA THERAPEUTICS
Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.
ALIA THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2018-01-01
Address:
Trento, Trentino-Alto Adige, Italy
Country:
Italy
Website Url:
http://www.aliatherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
5.7 M EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon WordPress Mobile Non Scaleable Content Organization Schema Sitelinks Search Box Yoast WordPress SEO Plugin Yoast Plugins
Similar Organizations
AAVantgarde Bio
AAVantgarde Bio is developing gene therapies for inherited retinal disorders.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Alcyone Therapeutics
Alcyone Therapeutics is Pioneering Next-Generation Precision CNS Genetic Therapies to unlock new possibilities
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Avrion Therapeutics
Avrion Therapeutics is a precision Gene Therapies for Neurodegenerative Diseases.
Borea Therapeutics
Borea Therapeutics is advancing a new generation of gene therapies that would enable the targeting of specific tissues and cells.
Modis Therapeutics
Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.
OcuTerra Therapeutics
OcuTerra Therapeutics is developing novel eye drop designed to treat diabetic eye disease.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Current Advisors List
Current Employees Featured
Founder
Investors List
BiovelocITA
BiovelocITA investment in Seed Round - Alia Therapeutics
Indaco Venture Partners
Indaco Venture Partners investment in Seed Round - Alia Therapeutics
Sofinnova Partners
Sofinnova Partners investment in Seed Round - Alia Therapeutics
Sofinnova Partners
Sofinnova Partners investment in Seed Round - Alia Therapeutics
Trentino Invest Srl
Trentino Invest Srl investment in Seed Round - Alia Therapeutics
BiovelocITA
BiovelocITA investment in Seed Round - Alia Therapeutics
Official Site Inspections
http://www.aliatherapeutics.com Semrush global rank: 5.44 M Semrush visits lastest month: 1.37 K
- Host name: carnage.evtel.com
- IP address: 18.156.43.197
- Location: Frankfurt am Main Germany
- Latitude: 50.1188
- Longitude: 8.6843
- Timezone: Europe/Berlin
- Postal: 60313
More informations about "Alia Therapeutics"
Alia Therapeutics - Crunchbase Company Profile
Next-generation gene editing medicines: Alia Therapeutics is focused on developing gene editing treatments aimed at curing rare genetic diseases by directly correcting genetic errors in patient cells.See details»
Alia People - Alia Therapeutics
Letizia Goretti. CEO. Letizia joins from Johnson & Johnson and has over 25 years of international life science industry experience. Letizia brings a broad background in strategic, operational, R&D and commercial activities across …See details»
Alia Therapeutics - LinkedIn
Alia Therapeutics is a pioneering gene editing company with a vision to revolutionize medicine by curing genetic diseases at their roots. Alia’s versatile portfolio of novel CRISPR systems ...See details»
Board of Directors - Alia Therapeutics
Adel Nada. Independent Board Member. Adel Nada is Co-founder and Chief Executive Officer of GentiBio, a biotherapeutics company developing engineered regulatory T cells programmed to …See details»
Company: Alia Therapeutics
Alia Therapeutics is a biotechnology company focused on developing CRISPR-based therapies to treat genetic diseases. Alia's research is centered on optimising gene-editing tools to improve safety, precision, and efficiency in …See details»
Alia Therapeutics - PitchBook
Alia Therapeutics General Information Description. Developer of gene editing technology designed to treat genetic diseases at their roots. The company offers a portfolio of advanced CRISPR systems that expand targetable genomic …See details»
Alia Therapeutics — Sofinnova Partners
Www.aliatherapeutics.com. Paola Pozzi. Partner, Sofinnova Partners - Telethon Strategy. Related News. 9 May, 2023 Alia Therapeutics appoints Adel Nada as Independent Board Director; 4 May, 2023 Alia Therapeutics names Letizia …See details»
Alia Therapeutics - Company Profile - Tracxn
Oct 22, 2024 Alia Therapeutics - Developer of gene therapies to cure rare genetic disorders. Raised a total funding of $4.84M over 2 rounds from 2 investors. Founded by Anna Cereseto, …See details»
Alia Therapeutics - VentureRadar
Similar Companies: Website: https://www.aliatherapeutics.com/ Alia Therapeutics Srl is an Italian biotech start-up whose mission is to develop innovative treatments ...See details»
Alia Therapeutics - Overview - aiHit
Www.aliatherapeutics.com; [email protected]; CLICK HERE TO SEE DETAILS OF COMPANY CHANGES. Alia Therapeutics Srl is an Italian biotech start-up which mission is to develop …See details»
Alia Therapeutics - INDACO
Www.aliatherapeutics.com. Investment Status. Ongoing. Alia Therapeutics is an Italian biotech start-up developing innovative treatments for incurable genetic diseases based on gene …See details»
Alia Therapeutics names Letizia Goretti as Chief Executive Officer
MILAN, May 5, 2023 — Alia Therapeutics, a Trento-based start-up specializing in innovative treatments for rare genetic diseases through next-generation gene editing technology, …See details»
Alia Therapeutics names Letizia Goretti as Chief Executive Officer
May 5, 2023 Alia Therapeutics , Friday, May 5, 2023, Press release picture. Letizia, who is joining Alia from Johnson & Johnson, has more than 25 years of international experience in life …See details»
Alia Therapeutics - Funding, Financials, Valuation & Investors
Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.See details»
Alia Therapeutics - Trentino Innovation
Https://www.aliatherapeutics.com. Social. Iscriviti alla nostra newsletter per sapere ogni notizia in anteprima! Iscriviti ora . Shareholders. Piazza Manci, 17 38123 Trento TN How to get. …See details»
Alia Therapeutics appoints Adel Nada as Independent Board Director
MILAN, May 9, 2023 — Alia Therapeutics, a Trento-based start-up specializing in innovative treatments for rare genetic diseases through next-generation gene editing technology, …See details»
Technology - Alia Therapeutics
Alia stems out of pioneering research of Professor Anna Cereseto and Doctor Antonio Casini at Trento University. Our thesis: The diversity and complexity of human genetic diseases …See details»
NVIDIA Partners With Industry Leaders to Advance Genomics,
4 days ago Arc Institute, a Palo Alto, California-based research organization operating at the intersection of biology and machine learning, is collaborating with NVIDIA to develop and …See details»
News - Alia Therapeutics
Alia Therapeutics celebrates the opening of its new headquarter and laboratory space within the new life science hub from Trentino Sviluppo S.p.A | Trentino Sviluppo S.p.A.; Alia …See details»
NVIDIA Partners With Industry Leaders to Advance Genomics, …
5 days ago J.P. Morgan Healthcare Conference—NVIDIA today announced new partnerships to transform the $10 trillion healthcare and life sciences industry by accelerating drug discovery, …See details»